CompaniesImmunovo

Immunovo

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

30

By Phase

PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
Today
NCT02237638
Hover over trial bars to see details

Recent Trials

NCT02237638Collaborator
Phase I Study on VEGF Vaccination in Metastatic Solid Tumors
PHASE1Completed
30 participants
Started: Apr 30, 2014 · Completed: Jan 1, 2020